Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Single-cell transcriptomics identifies regulatory T cell heterogeneity in gestational diabetes mellitus.
PMID 41933176 · PMC13223204 · Communications medicine · 2026 · 8 claims · 8 setups
Treg cluster proportions do not significantly differ between GDM and healthy control patients
-
Has reproduction · 40
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127(+) and KLRG1(+) CD8 T cells.
PMID 37231145 · PMC10213055 · NPJ precision oncology · 2023 · 8 claims · 5 setups
NAPC produces higher major pathological response (MPR) and pathological complete response (pCR) rates and longer DFS/OS than NAC alone
-
Full-text index only
Translation factor eIF4G2 directs CD8(+) T cell lineage commitment by selectively enabling the IL-7 receptor response.
PMID 41940334 · PMC13049607 · iScience · 2026 · 8 claims · 8 setups
eIF4G2 expression is markedly upregulated in DP thymocytes relative to DN thymocytes
-
Full-text index only
pmid-42070154
PMID 42070154 · PMC13135724 · 8 claims · 5 setups
LOY has cell type-specific effects on immune cells, with the highest prevalence in classical monocytes, that vary along differentiation trajectories
-
Has reproduction · 72
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
PMID 38897205 · PMC11293361 · Cell reports. Medicine · 2024 · 8 claims · 8 setups
Neoadjuvant sintilimab plus carboplatin/nab-paclitaxel is clinically feasible and tolerable in resectable EGFR-mutant NSCLC, with all 18 patients completing treatment and undergoing radical surgery.
-
Full-text index only
Development and validation of a potency assay matrix for optimized and consistent manufacture of clinical mesenchymal stem/stromal cells.
PMID 41798920 · PMC12960169 · Frontiers in immunology · 2026 · 8 claims · 8 setups
MSCs consistently suppress T cell proliferation
-
Has reproduction · 48
Irisin ameliorates obesity and insulin resistance via adipose tissue IL-33 and regulatory T cells.
PMID 41933175 · PMC13052164 · Nature metabolism · 2026 · 8 claims · 8 setups
Irisin modulates adipose tissue inflammation by increasing IL-33 production and preserving ST2+ regulatory T cells in white adipose tissues, thereby improving obesity and glucose intolerance.